Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Hydration is biggest Ramadan health concern, Clinova finds

Hydration is the biggest health concern for Muslims during Ramadan, according to a poll conducted by Clinova.


A survey of 118 Muslims, conducted during Ramadan last year, revealed that 81 per cent had issues with hydration during the month-long fast, the manufacturer said. Muslims observing Ramadan – which began last week – must not eat or drink during daylight.


Fifty-seven per cent of respondents to Clinova’s survey said they found it difficult to drink enough water to remain “adequately hydrated” during non-fasting night hours, and the manufacturer suggested that its O.R.S Hydration Tablets could provide additional hydration if necessary.


The “convenient, soluble” tablets contained a formula of oral rehydration salts and were available in lemon, blackcurrant and strawberry flavours, it added.


Packs of 12 tablets retail at £4.99; 24 tablets are £6.99.


To order, contact 0845 6525063

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD007514

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel